Influence of font sizes on the readability and comprehensibility of package inserts

Pharmazeutische Industrie

Volumn 70, Issue 5, 2008, Pages 584-592

  Fuchs, Jörg ^a,b   Heyer, Tina ^a,c   Langenhan, Diana ^a,c   Hippius, Marion ^c  

^a PAINT Consult   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DRUG INFORMATION; DRUG MARKETING; DRUG PACKAGING; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; PRACTICE GUIDELINE; READING; VISUAL IMPAIRMENT;

EID: 47949115656     PISSN: 0031711X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. United Nations. International Covenant on Civil and Political Rights. Adopted and opened for signature, ratification and accession by General Assembly resolution 2200A (XXI) 1966 Dec 16, entry into force 1976 Mar 23, in accordance with Article 49. http://www.ohchr.org/english/law/ccpr.htm, 16 September 2007.
2. United Nations. The standard rules on the equalization of opportunities for persons with disabilities. December 20, 1993. http://www.un.org/esa/ socdev/enable/dissre00.htm, 29 January 2008.
3. th November 2001 on the Community code relating to medicinal products for human use. OJ. 2001;L311:67-128.
4. st March 2004 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use. OJ. 2004;L136:34-57.
5. Twomey C. An analysis of patient information leaflets supplied with medicines sold by pharmacies in the United Kingdom. Library and Information Research News. 2001;25(80):3-12.
6. Van der Stichele RH, Van Haecht CH, Braem MD, Bogaert MG. Attitude of the public toward technical package inserts for medication information in Belgium. Ann Pharmacother. 1991;25:1002-06.
7. Van Haecht CHM, Van der Stichele RH, De Backer G, Bogaert MG. Impact of patient package inserts on patients satisfaction adverse drug reactions and risk perception: The case of NSAIDs for posttraumatic pain relief. Patient Educ Couns. 1991;17:205-15.
8. Shrank W, Avorn J, Rolon C, Shekelle P. Effect of content and format of prescription drug labels on readability, understanding and medication use: A systematic review. Ann Pharmacother. 2007;41:783-801.
9. Fuchs J, Banow S, Görbert N, Hippius M. The importance of package insert information in the European Union. Pharm Ind. 2007;69:165-172.
10. Bernardini C, Ambrogi V, Fardella G, Perioli L, Grandolini G. How to improve the readability of the patient package leaflet: a survey on the use of colour, print size and layout. Pharmacol Res. 2001;5:437-43.
11. Fuchs J, Hippius M, Schaefer M. A survey of package inserts use by patients. Hospital Pharmacy Europe. 2005;4:29-31.
12. Spencer H. The visible word. London: Royal College of Art; 1968.
13. Ekstrom I. Printed Materials for an Aging Population: Design Considerations. J Biocommunication. 1993;20:25-30.
14. European Commission. A guideline of the readability of the label and package leaflet of medicinal products for human use. September 29, 1998. http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/vol-2/c/gl981002. pdf, 29 January 2008.
15. Fuchs J, Hippius M, Schaefer M. Analysis of German package inserts. Int J Clin Pharmacol Ther. 2006;44:8-13.
16. Nink K, Schröder H. Zu Risiken und Nebenwirkungen: Lesen Sie die Packungsbeilage? Bonn: WidO [Wissenschaftliches Institut der Ortskrankenkassen]; 2005.
17. European Commission. Guideline on the readability of the label and package leaflet of medicinal products for human use. September 2006. http://ee.europa.eu/enterprise/pharmaceuticals/pharmacos/docs/doc2006/ 09_2006/readability_consultation_2006_09_25.pdf, 29 January 2008.
18. European Blind Union. Making your Information accessible for customers with sight problems. November 2003. http://www.euroblind.org/fichiersGB/ policy.htm, 29 January 2008.
19. Royal National Institute for the blind. RNIB clear print guidelines. September 29, 2006. http://www.rnib.org.uk/xpedio/groups/public/documents/ publicwebsite/public_printdesign.hcsp#P6_523, 19 July 2007.
20. Boyce PR. Human Factors in Lighting. London: Applied Science Publishers; 1981.
21. Paterson DG, Tinker MA. Studies of typographical factors influencing speed of reading: II size of type. J Appl Psychol. 1929;13(2):120-30.
22. Paterson DG, Tinker MA. How to make type readable. New York: Harper & Brothers; 1940.
23. Paterson DG, Tinker MA. Influence of size of type on eye movements. J Appl Psychol. 1942;26:227-30.
24. Fuchs J, Hippius M. Inappropriate dosage instructions in package inserts. Patient Educ Couns. 2007;67:157-68.
25. BfArM [Bundesinstitut für Arzneimittel und Medizinprodukte]. Welche Methoden sind vom BfArM für die Durchführung einer solchen Untersuchung akzeptiert? [Which methods are accepted by the BfArM to perform a readability test?]. January 10, 2007. http://www.bfarm.de/cln_043/nn_424304/ SharedDocs/FAQ/DE/Arzneimittel/pal/fa-ampal-faq.html, 29 January 2008.
26. European Commission. Guidance concerning consultations with target patient groups for the package leaflet. May 2006. http://ec.europa.eu/ enterprise/pharmaceuticals/eud ralex/vol-2/c/user_consultation_200605.pdf, 29 January 2008.
27. Aberson DHA, Bouwhuis DG. Silent reading as determined by age and visual acuity. J Res Reading. 1997;20(3):184-204.
28. Zacchrisson B. Studies in the legibility of printed text. Stockholm Göteborg Uppsala: Almqvist & Wiksell; 1965.
29. Watanabe RK. The ability of the geriatric population to read labels on over-the-counter medication containers. J Am Optometr Assoc. 1994;65:32-37.
30. Bix L. The elements of text and message design and their impact on message legibility: a literature review. J Design Commun. 2002;4.
31. Frost MH, Thompson R, Thiemann KB. Importance of format and design in print patient information. Cancer Practice. 1999;7:22-27.
32. Secker J. Assessing the quality of patient-education leaflets. Coronary Health Care. 1997;1:37-41.
33. Hartley J. Designing instructional text for older readers: A literature review. Brit J Educ Technol. 1994;25(3):172-88.
34. Eyles P, Skelly J, Schmuck ML. Evaluating patient choice of typeface style and font size for written health information in an outpatient setting. Clin Effectiveness Nurs. 2003;7:94-98.
35. Kirkpatrick MAF, Mohler CP. Using the readability assessment instrument to evaluate patient medication leaflets. Drug Inform J. 1999;33:557-63.
36. Singh J. Development of an alternative methodology for determining the readability of text [dissertation]. Richmond: Virginia Commonwealth University; 1994.
37. Smither JA, Braun CC. Readability of prescription drug labels by older and younger adults. J Clin Psychol Med Settings. 1994;1(2):149-59.
38. Prince JH. Printing for the visually handicapped. J Typogr Res. 1967;1:31-47.
39. Vanderplas JM, Vanderplas JH. Some factors affecting legibility of printed materials for older adults. Percept Motor Skills. 1980;50:923-32.
40. Drummond SR, Drummond RS, Dutton GN. Visual acuity and the ability of the visually impaired to read medication instructions. Brit J Ophthalmol. 2004;88:1542-42.
41. Mathers CD, Bernard C, Iburg KM, Inoue M, Fat DM, Shibuya K, et al. Global Burden of Disease study 2000-2002: data sources, methods and results. GPE Discussion Paper No. 54. Geneva: World Health Organization; 2003. http://www.who.int/healthinfo/statistics/gbdestimates-casedefinitions. pdf, 29 January 2008.
42. European Blind Union. Guidelines regarding implementation of the European Union Directive on medicinal products for human use - package information leaflets (or patient information leaflets) (PIL) accessible for visually impaired end-users. http://www.euroblind.org/fichiersGB/pil-guid.htm, 16 September 2007.
43. Eurostat. Total population at 1 January 2008. http://epp.eurostat.ec. europa.eu/portal/page?_pageid=1996,39140985&_dad=portal&__schema=P ORTAL&screen=detailref&language=en&product= Yearlies_new_population&root=Yearlies_new_population/C/C1/C11/caa10000, 29 January 2008.
44. European Union. Consolidated versions of the treaty on European Union and of the treaty establishing the European community. OJ. 2002;C325:1-184.